Abstract: Gene expression profiling in patients with mCRPC identifying genes that predict overall survival in response to treatment with sipuleucel-T, the method comprising the steps of (a) determining a gene expression level of a first biomarker; (b) determining a gene expression level of at least one additional biomarker different from the first biomarker; and (c) transforming the expression level of the first biomarker and the at least one additional biomarker into a first score corresponding to a probability of overall survival in response to treatment with sipuleucel-T.
Type:
Grant
Filed:
September 9, 2019
Date of Patent:
April 30, 2024
Assignee:
Dendreon Pharmaceuticals LLC
Inventors:
James B. Trager, Nadeem A. Sheikh, Debraj GuhaThakurta, Harini Kandadi, Li-Qun Fan